Scientists are testing CRISPR gene editing as a potential HIV cure after successfully removing the virus from infected cells ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, ...

– Investigational Long-Acting, Twice-Yearly Treatment Regimen of Lenacapavir and Broadly Neutralizing Antibodies (bNAbs) Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy ...

Researchers found that lithium can suppress HIV reactivation in lab-grown human cells through an unexpected, ...

SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...

UCSF researchers recently gave an overview of their latest work launching a new Institute for HIV Cure Research, funded by a $20 million grant from amfAR, the Foundation for AIDS Research. Cure ...

"Cure" was the fresh buzzword among researchers at the XIX International AIDS Conference. It was the focus of a two-day pre-conference workshop and a new initiative by the International AIDS Society ...

S1: Hey there , San Diego. It's Andrew Bracken in for Jade Hindman. Today , what do cuts in federal funding mean for the future of HIV and Aids programs around the world ? Plus , how progress being ...